ppearance, they are often overlooked as an aesthetic treatment area. I’m pleased to have a new treatment option that I can recommend to my patients to help restore youthful proportions by effectively improving temple hollowing. This latest approval for Restylane Contour, offering dual-depth injection flexibility, will help me deliver harmonious, natural-looking results across the midface and temples that suit my patients’ unique features.”

MARK NESTOR, M.D., Ph.D.
BOARD CERTIFIED DERMATOLOGIST AND DERMATOLOGIC SURGEON**
UNITED STATES








The approval is based on clinical results showing that Restylane Contour improved temple hollowing compared with no treatment at three months, with results lasting for up to 18 months, and high investigator and patient (clinical trial participant) satisfaction:1,2


Efficacy:


91% of patients were conside
=*=*=*=*=*=
当前为第4/15页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页